Trials / Unknown
UnknownNCT01013116
Evaluation of Efficacy and Safety of Specific Immunotherapy With Modified Allergen Extracts of House Dust Mites
A Double-blind Placebo-controlled Trial to Evaluate Efficacy and Safety of Specific Subcutaneous Immunotherapy in Patients With Perennial Allergic Rhinitis Due to House Dust Mites
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Roxall Medizin · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the efficacy and safety of specific subcutaneous immunotherapy with modified allergen extracts.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | modified allergen extract of house dust mites | subcutaneous injections |
| BIOLOGICAL | placebo | subcutaneous injections |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2017-04-01
- Completion
- 2017-04-01
- First posted
- 2009-11-13
- Last updated
- 2015-11-03
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01013116. Inclusion in this directory is not an endorsement.